Insights into Shingles Vaccine with Dr Anantha Padmanabha

Published On 2024-03-14 09:43 GMT | Update On 2024-03-14 09:43 GMT

In this video, Dr Anantha Padmanabha discusses Herpes zoster, caused by the varicella-zoster virus, targeting primarily older adults, particularly those aged 50 and above, as well as individuals with compromised immune systems and presenting as a painful rash along specific nerve pathways.

With a keen focus on diagnosis methods, he outlines the key indicators used by healthcare professionals to identify shingles, emphasizing the importance of prompt recognition and treatment.

He also sheds light on the potential complications, including the debilitating post-herpetic neuralgia, which can linger long after the rash has subsided and can significantly impact the quality of life for those affected.

Lastly. Dr Padmanabha talks about the shingles vaccine—a vital tool in prevention and elaborates on the two-dose regimen, spaced over several months while underscoring its proven efficacy in reducing the risk of shingles development, as well as alleviating symptom severity in breakthrough cases.

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Rishika Verma

Rishika joined Medical Dialogues in the year 2023 and is currently working as PR Coordinator . She is a graduate from Delhi University . She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Insights into Shingles Vaccine with Dr Anantha Padmanabha

Similar News

Hepatitis B Vaccine May Lower Diabetes Risk: Study Finds

PCV20 Launch in India: A Single Dose, Science-Driven Approach for Pneumococcal Disease Control

Maternal RSV Vaccine Cuts Infant Hospitalizations by 72 Percent: Study Finds

COVID-19 Vaccination Reduces Dialysis and Mortality Risk in Acute Kidney Injury Patients: Study

New mRNA Vaccine May Be More Effective Against Evolving Viruses: Study Shows

Milan Faces Measles Threat as Single Virus Lineage Drives New Outbreak: Study

New Oral Cholera Vaccine by Bharat Biotech Passes Phase III Clinical Trial: Study

Study Shows How Shingles Vaccine May Also Protect Your Heart